AQR Capital Management - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q1 2023$1,405,197
+92.8%
35,911
+125.7%
0.00%
+50.0%
Q4 2022$728,702
+72.3%
15,914
+55.7%
0.00%
+100.0%
Q3 2022$423,000
-53.3%
10,222
+7.6%
0.00%
-50.0%
Q2 2021$906,000
-72.4%
9,500
-67.0%
0.00%
-60.0%
Q1 2021$3,277,000
-37.7%
28,784
-24.3%
0.01%
-44.4%
Q4 2020$5,263,000
+120.4%
38,018
+30.8%
0.01%
+125.0%
Q3 2020$2,388,000
+11.1%
29,059
+5.7%
0.00%
+33.3%
Q2 2020$2,150,000
+104.6%
27,483
+16.2%
0.00%
+50.0%
Q1 2020$1,051,000
+353.0%
23,647
+335.7%
0.00%
Q4 2019$232,000
-49.8%
5,427
-25.5%
0.00%
-100.0%
Q2 2019$462,000
+35.1%
7,283
-7.3%
0.00%
Q4 2018$342,000
-34.9%
7,858
+14.2%
0.00%
-100.0%
Q3 2018$525,000
+67.2%
6,882
+7.2%
0.00%0.0%
Q2 2016$314,000
-73.0%
6,419
-65.0%
0.00%
-50.0%
Q1 2016$1,161,000
-68.7%
18,343
-44.6%
0.00%
-66.7%
Q4 2015$3,712,000
+10.8%
33,093
-4.8%
0.01%
-14.3%
Q3 2015$3,349,000
+44.7%
34,777
+53.9%
0.01%
+40.0%
Q2 2015$2,314,00022,5920.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders